Company / SG&A per Share
GT Biopharma, Inc. SG&A per Share History
FY2011-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.38
FY2020
5-year range
$0.00 / $80.59
FY2016-FY2020
Trend
-97.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $3.31 to $2.38 over the past 4 years.
Based on SEC 10-K filings.
2.38 in FY2020 with a 5-year CAGR of +18.7%.
Improved from $3.31 to $2.38 over the past 4 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -69.1%
- 5-Year CAGR
- +18.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, sg&a per share decreased 97.0% year-over-year.
- Peak sg&a per share was recorded in FY2017.
- Lowest sg&a per share in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $2.38 | -97.0% |
| FY2017 | $80.59 | +2331.7% |
| FY2016 | $3.31 | +226.8% |
| FY2015 | $1.01 | +62054.2% |
| FY2014 | $0.00 | -75.7% |
| FY2013 | $0.01 | -47.9% |
| FY2012 | $0.01 | -14.9% |
| FY2011 | $0.02 | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026